Conflict of Interest (from DOI: 10.1007/s11886-020-01292-3)

Navigation

Article	Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
Sections in this Publication
Section	Section 1: Introduction (from DOI: 10.1007/s11886-020-01292-3)
Section	Section 2: Biology of SARS-CoV-2 (from DOI: 10.1007/s11886-020-01292-3)
Section	Section 3: The Role of Host Immune Response (from DOI: 10.1007/s11886-020-01292-3)
Section	Section 4: Viral Toxicity and Myocardial Injury in COVID-2 (from DOI: 10.1007/s11886-020-01292-3)
Section	Section 5: Immune Responses to SARS-CoV-2 Infection and the Heart (from DOI: 10.1007/s11886-020-01292-3)
Section	Section 6: Host-Specific Variations in COVID-19 Immune Response (from DOI: 10.1007/s11886-020-01292-3)
Section	Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3)
Section	Section 8: Conclusion (from DOI: 10.1007/s11886-020-01292-3)
Section	Conflict of Interest (from DOI: 10.1007/s11886-020-01292-3)
Section	References (from DOI: 10.1007/s11886-020-01292-3)
Named Entities in this Section
Entity	microtubule affinity regulating kinase 1 (gene)
Entity	Human (species)
Dataset	Pubtator Central BioC-JSON formatted article files

From publication: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" published as Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32. DOI: https://doi.org/10.1007/s11886-020-01292-3

Conflict of Interest

Han Zhu, June Rhee, Paul Cheng, Sarah Waliany, Amy Chang, Ronald M. Witteles, Holden Maecker, Mark M. Davis, Patricia K. Nguyen, and Sean M. Wu declare that they have no conflict of interest.

This article does not contain any studies with human or animal subjects performed by any of the authors.